glp-1 pregnancy Study finds no major early risks tied to drugs, but doctors still advise against use Reconciling GLP-1s and Pancreatitis

Incidences of other toxicities were comparable across the three treatment groups in DURATION-8 (exenatide plus dapagliflozin, exenatide alone, and dapagliflozin alone, respectively), including pancreatitis (1.3%, 0.4%, and 0%), volume depletion (1.3%, 0.4%, and 2.1%), gastrointestinal events (20.8%, 23.9%, and 16.3%), and genital infections (5.2%, 2.2%, and 7.7%) [36]

Davidson K, MScFN, RD, et al

Very pleased with Willow Gay C

Deficiencies in these nutrients are common during rapid weight loss and can exacerbate shedding

Researchers who study the pancreatic peptide hormone system will recognize glucagon as the metabolic counterweight to insulin, and harnessing it pharmacologically opens therapeutic possibilities that the research community has pursued for decades